Holen Sie sich die Stockscreener-App
1.63
3.55%
-0.06
Handel nachbörslich:
1.64
0.01
+0.61%
Schlusskurs vom Vortag:
$1.69
Offen:
$1.69
24-Stunden-Volumen:
175.86K
Relative Volume:
0.08
Marktkapitalisierung:
$5.36M
Einnahmen:
$12.99M
Nettoeinkommen (Verlust:
$-23.72M
KGV:
-0.0168
EPS:
-97.2514
Netto-Cashflow:
$-23.28M
1W Leistung:
-4.12%
1M Leistung:
-37.07%
6M Leistung:
-97.24%
1J Leistung:
-99.38%
1-Tages-Spanne:
$1.56
$1.6922
1-Wochen-Bereich:
$1.56
$1.73
52-Wochen-Spanne:
$1.56
$381.10
Aptevo Therapeutics Inc Stock (APVO) Company Profile
Firmenname
Aptevo Therapeutics Inc
Sektor
Branche
Telefon
206-838-0500
Adresse
2401 4TH AVE., SEATTLE, WA
Vergleichen Sie APVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
1.63 | 5.26M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-11-05 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-10-05 | Fortgesetzt | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc Aktie (APVO) Neueste Nachrichten
Is Aptevo Therapeutics Inc. currently under institutional pressureJuly 2025 Earnings & Intraday High Probability Setup Alerts - khodrobank.com
Visual analytics tools that track Aptevo Therapeutics Inc. performance2025 Price Targets & AI Optimized Trading Strategy Guides - Newser
Historical volatility pattern of Aptevo Therapeutics Inc. visualizedGap Down & Real-Time Stock Entry Alerts - Newser
How institutional ownership impacts Aptevo Therapeutics Inc. stockMarket Performance Summary & AI Forecasted Entry and Exit Points - Newser
Ranking Aptevo Therapeutics Inc. among high performing stocks via toolsEarnings Growth Report & High Return Stock Watch Alerts - Newser
Automated trading signals detected on Aptevo Therapeutics Inc.Day Trade & Stepwise Swing Trade Plans - Newser
Aptevo Therapeutics Inc. stock daily chart insightsJuly 2025 Trade Ideas & Weekly High Conviction Trade Ideas - Newser
Why Aptevo Therapeutics Inc. is moving todayBuy Signal & Safe Capital Investment Plans - Newser
Risk vs reward if holding onto Aptevo Therapeutics Inc.Analyst Upgrade & Weekly High Conviction Ideas - Newser
Is Aptevo Therapeutics Inc. a defensive stock2025 Technical Patterns & Low Risk High Reward Ideas - khodrobank.com
Will breakout in Aptevo Therapeutics Inc. lead to full recovery2025 Year in Review & Stock Timing and Entry Methods - Newser
Can technical indicators confirm Aptevo Therapeutics Inc.’s reversalGap Up & AI Forecast Swing Trade Picks - Newser
Institution Moves: What drives Aptevo Therapeutics Inc.’s stock price2025 Growth vs Value & Accurate Buy Signal Notifications - khodrobank.com
Can volume confirm reversal in Aptevo Therapeutics Inc.July 2025 Analyst Calls & Community Verified Watchlist Alerts - Newser
News impact scoring models applied to Aptevo Therapeutics Inc.2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser
What drives Aptevo Therapeutics Inc.’s stock priceWeekly Risk Report & Expert Approved Momentum Trade Ideas - khodrobank.com
Is Aptevo Therapeutics Inc. showing insider buyingPortfolio Return Report & Risk Controlled Daily Plans - khodrobank.com
Is Aptevo Therapeutics Inc. likely to announce a buybackWeekly Market Summary & Pattern Based Trade Signal System - khodrobank.com
Can Aptevo Therapeutics Inc. navigate macro headwindsGDP Growth & Real-Time Price Movement Reports - khodrobank.com
Is Aptevo Therapeutics Inc. impacted by rising ratesEarnings Miss & Reliable Price Breakout Signals - khodrobank.com
Key resistance and support levels for Aptevo Therapeutics Inc.2025 Biggest Moves & Verified Entry Point Detection - Newser
Published on: 2025-09-02 03:29:00 - Newser
Is Aptevo Therapeutics Inc. stock reversal real or fake2025 Technical Overview & Smart Investment Allocation Insights - Newser
Will Aptevo Therapeutics Inc. benefit from sector rotationMarket Sentiment Report & Consistent Profit Trading Strategies - khodrobank.com
Published on: 2025-09-01 20:43:15 - Newser
Is Aptevo Therapeutics Inc. in a long term uptrendWatch List & Consistent Income Trade Recommendations - khodrobank.com
Real time pattern detection on Aptevo Therapeutics Inc. stockQuarterly Investment Review & Safe Entry Momentum Tips - Newser
Real time social sentiment graph for Aptevo Therapeutics Inc.July 2025 Technicals & Accurate Intraday Trading Signals - Newser
What MACD and RSI say about Aptevo Therapeutics Inc.2025 Buyback Activity & Stepwise Entry and Exit Trade Signals - Newser
Is Aptevo Therapeutics Inc. reversing from oversold territoryMarket Movers & Fast Exit Strategy with Risk Control - Newser
Is Aptevo Therapeutics Inc. forming bullish engulfing patternsJuly 2025 Drop Watch & Low Risk High Reward Trade Ideas - kpenews.com
Can momentum traders help lift Aptevo Therapeutics Inc.2025 Institutional Moves & Growth Focused Stock Pick Reports - Newser
Custom watchlist performance reports with Aptevo Therapeutics Inc.July 2025 Selloffs & Short-Term High Return Ideas - Newser
Technical Heatmap Flags Aptevo Therapeutics Inc. for WatchMarket Movement Recap & Risk Managed Investment Signals - beatles.ru
Published on: 2025-08-31 00:36:04 - Newser
How to manage a losing position in Aptevo Therapeutics Inc.July 2025 Institutional & Real-Time Stock Movement Alerts - Newser
Can Aptevo Therapeutics Inc. expand into new markets2025 Key Lessons & Capital Efficiency Focused Ideas - kpenews.com
Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):